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Here we describe the cloning of a sequenced WUMS isolate of murine gammaherpesvirus-68 (MHV-68, γHV-68, also known
as MuHV-4) as a bacterial artiﬁcial chromosome (BAC). We engineered the insertion of the BAC sequence ﬂanked by loxP sites
into the left end of the viral genome before the M1 open reading frame. The infectious viruses were reconstituted following
transfection of the MHV-68 BAC DNA into cells. The MHV-68 BAC-derived virus replicated indistinguishably from the wild-type
virus in cultured cells. Excision of the BAC insert was eﬃciently achieved by coexpressing the Cre recombinase. Although the
BAC insertion did not signiﬁcantly aﬀect acute productive infection in the lung, it severely compromised the ability of MHV-68 to
establishsplenic latency. Removal of the BAC sequence restored thewild-type level of latency. Site-speciﬁc mutagenesis was carried
out by RecA-mediated recombination to demonstrate that this infectious BAC clone can be used for genetic studies of MHV-68.
1.Introduction
Two human gamma-herpesviruses, Kaposi’s sarcoma-
associated herpesvirus (KSHV or HHV-8), and Epstein-Barr
virus (EBV), are implicated in multiple malignancies.
Like other herpesviruses, they establish life-long persistent
infections, interchanging between lytic replication and
latency, while being subjected to the control of the host
immune system. An enormous amount of knowledge has
been built on the molecular biology of KSHV and EBV.
However, due to the lack of a small animal model, the studies
on the in vivo interplay between the virus and the host
during persistent infections have been limited.
Murine gammaherpesvirus 68 (MHV-68, γHV-68, also
known as MuHV-4), originally isolated from wild rodents,
was found to be closely related to KSHV/HHV-8 and EBV
[1–4].Followingintranasalinoculationintolaboratorymice,
MHV-68 ﬁrst replicates in lung epithelial cells to produce
infectious viruses and then establishes latency in B cells
[5, 6]. Remarkably, massive lymphoproliferation that occurs
at about two weeks after infection resembles infectious
mononucleosis seen in some individuals experiencing pri-
mary EBV infection [7, 8]. Persistent infections of MHV-
68 also lead to B-cell lymphomas in a small fraction
of mice and the tumor incidence increases in immuno-
deﬁcient mice [9]. The genome of MHV-68 was completely
sequenced[1]andthemajorityoftheidentiﬁedopenreading
frames (ORFs) share homology to those of KSHV and
EBV. However, unlike human gamma-herpesviruses, MHV-
68 readily infects a variety of cell lines and undergoes lytic
replication. Therefore, MHV-68 represents a valuable model
to study not only the virus-host interactions but also viral
lytic replication of gamma-herpesviruses.
In virology, genetic mutagenesis is the primary approach
to examine the role of a viral gene. Mutations are introduced
into a speciﬁc gene on the viral genome and the phenotype2 Journal of Biomedicine and Biotechnology
of the resultant mutant virus is studied. Herpesviruses have
rather large DNA genomes up to 250kb and thus the mutant
virus is generated by homologous recombination between
the viral genome and the DNA fragment carrying the
desired genetic alterations. This method is time consuming
because the mutant virus needs to be separated from the
parental virus by multiple rounds of plaque puriﬁcations or
limiting dilutions. It would be even more cumbersome to
generate the mutants that are defective in viral replication. A
breakthrough in genetic mutagenesis of herpesviruses came
from the method that was established to clone the entire
herpesviral genome into a bacterial artiﬁcial chromosome
(BAC) [10–16]. BAC, a vector derived from F factor of E.
coli., has the capacity to accommodate a large insert (up to
300Kb) and stably maintain it in bacterial hosts. Once the
viral genome is cloned and propagated as a BAC plasmid
in E. coli,i tc a nb ee ﬃciently modiﬁed using the well-
developed bacterial genetic methods. The cloning method
exploits the fact that the linear herpesviral DNA within an
infectious viral particle becomes circularized once entering a
cell. For cloning of the herpesviral genome, the ﬁrst step is
to construct a recombinant virus that contains the insertion
of the BAC sequence at a tolerable site, and then this BAC-
containing virus is used to infect permissive cells. Next,
the circularized BAC-containing viral DNA is harvested
from the infected cells and used to transform E. coli to
obtain colonies, each of which harbors a viral BAC. Two
majorrecombinationsystemshavebeenusedforsite-speciﬁc
mutagenesis of viral BACs. One is RecA-mediated allelic
exchange [17], relying on the shuttle plasmid to transfer the
mutation ﬂanking by at least 350-bp homologous sequences
into the viral BAC plasmid. The other is carried out by
recombinases E and T between linear DNA fragment and
the BAC plasmid, which only requires a 50-bp homologous
region on either site of the mutation [18]. However, ET-
recombination might suﬀer from a higher risk of illegitimate
recombination.
In order to eﬃciently and systematically study the
functions of individual viral genes encoded by MHV-68,
we decided to clone the sequenced WUMS isolate [1]a sa
BAC plasmid. After obtaining the MHV-68 BAC plasmid,
we conducted transposon-mediated random insertional
mutagenesis to systematically identify the viral ORFs
essential for viral replication [19]a sw e l la st of u n c t i o n a l l y
proﬁle a genetic locus in great details [20]. Due to the
extensive use of our MHV-68 BAC plasmid in the ﬁeld, we
describe here the construction and characterization of this
MHV-68 BAC. The BAC sequence ﬂanked by the loxP sites
was inserted into upstream of the leftmost open reading
frame, M1. The infectious viruses were reconstituted after
transfection of the MHV-68 BAC plasmid and shown to
replicate indistinguishably compared to the wild-type virus.
However, we found that the excision of the BAC sequence
from the reconstituted viruses by Cre/loxP recombination is
necessary for the in vivo study. After verifying the MHV-68
BAC clone we generated, mutagenesis was carried out to
explore the role of ORF11. ORF11 is conserved among
gamma-herpesviruses, but it does not have any assigned
function. Nonsense mutations were inserted near the
N-terminus of ORF11 on the MHV-68 BAC by a RecA-
mediated mutagenesis system. Disruption of ORF11 had no
eﬀect on viral replication in vitro or on viral infection in vivo
following intranasal inoculation into Balb/c mice.
2.MaterialsandMethods
2.1. Virus and Cells. MHV-68 was originally obtained from
the American Type Culture Collection (VR1465). The
working virus stocks were grown by infecting BHK-21 cells
(ATCC CCL-10) at a multiplicity of infection (MOI) of
0.05PFU/cell. BHK-21 and 293T cells were cultured in
Dulbecco’s-modiﬁed Eagle’s medium (DMEM) plus 10%
fetal bovine serum and NIH3T3 cells were cultured in
DMEM plus 10% bovine calf serum. The plaque assays were
performed on BHK-21 cells as previously described [21].
2.2. Plasmids. The pBAC(loxP) plasmid was constructed
from pBeloBAC11 by inserting a second copy of loxP
sequence. This was achieved by annealing two oligonu-
cleotides (loxP4 and loxP5, listed in Table 1) and cloning
into the unique BamHIa n dSfoI sites of pBeloBAC11.
The puromycin expression cassette derived from pTW39
which contains the puromycin coding sequence driven by
the CMV promoter was inserted into pBAC(loxP) to create
pBAC(loxP+PUR). pBAC(loxP+PUR) was then linearized at
the unique ClaI site between two loxP sites, blunted and
cloned into the unique StuIs i t ei nt h eM H V - 6 8g e n o m e
region (nt 106–4340) [1] to generate the targeting plasmid
pTW64 for homologous recombination.
The shuttle plasmids used for allelic exchange are derived
from pGS284 [15]. The translational stop codons were
introducedintothetargetedORFbyPCR.ThePCRreactions
were carried out as suggested by the manufacturer using
a proof-reading enzyme, Vent DNA polymerase (Biolab)
and the cycle number was limited to 25. The sequences
upstream of the stop codons (A fragments) were ampliﬁed
by primers of AF and AR while the downstream sequences
(B fragments) were by primers of BF and BR using wild-
type MHV-68 virion DNA as the template. The A and
B fragments were designed to have a 21bp overlapping
sequence containing restriction enzyme sites BamHIa n d
PacI for later screening purposes. In a subsequent PCR
reaction, the A and B fragments were used as templates and
ampliﬁed by primers of AF and BR. The ﬁnal PCR products
were digested with appropriate enzymes and cloned into
pGS284.TheresultantshuttleplasmidpORF11S(GS284)was
sequenced before used for allelic exchange. All the primers
used to construct the shuttle plasmid were listed in Table 1.
2.3. Virus Construction. The MHV-68(BAC) was generated
by cotransfecting pTW64 linearized with AvrII and the
MHV-68(EGFP) virion DNA into BHK-21 cells. At 5 days
after transfection, the pool of MHV-68(BAC) and MHV-
68(EGFP) was subjected to limiting dilution. The recom-
binant MHV-68(BAC) candidates were selected by the loss
of enhanced green ﬂuorescent protein expression. Their
genomic structures were analyzed by Southern blots and the
correct recombinant was identiﬁed.Journal of Biomedicine and Biotechnology 3
Table 1: Sequences of the primers.
Primer name Sequence Position (MHV-68 sequence)
loxP4 GATCCATAACTTCGTATAATGTATGCTATA
CGAAGTTAT TTAAATATCGATGCTAGCG
loxP5 CCGCTAGCATCGATTTAAATAACTTCGTAT
AGCATACATTATACGAAGTTATG
AF TCTCCTCGAGggttgaatgcatcttgtagg 59095–59114
AR GGATCCTTAATTAATTGACCGGgcctcaccgctcatctgaaa 59479–59498
BF CCGGTCAATTAATTAAGGATCCtgggtagatccaggagagat 59499–59518
BR CTATGCTAGCgatctagcaaacctctggga 59948–59929
The non-MHV-68 sequences of primers are in caps. The italic indicates the engineered restriction enzymes. For loxP4 and loxP5, NheI, ClaI, and SwaIw e r e
added next to the loxP sequence (underlined) for cloning purposes. For AF and BR, XhoIa n dNheI sites were introduced into the primers, respectively, for
cloning into pGS284. For AR and BF, BamHIa n dPacI were included in the primers for screening purposes.
2.4. Isolation of Viral DNA and BAC Plasmids. Virion
DNA was harvested from viral particles released from cells.
Generally four 10-cm plates of BHK-21 cells were infected at
MOI of 0.05PFU/cell. At the time when 50–80% cells were
detached from the plate, the supernatants were harvested
and clariﬁed twice by spinning down cell debris for 15min
at 1500rpm, followed by digestion of DNaseI (5μg/ml) and
RNaseA (5μg/ml) in the presence of 3mM of MgCl2 and
CaCl2 at 37◦C for 30min. The treated supernatants were
subjected to high-speed centrifugation in a SA-600 rotor
(Sovall) at 12,000rpm for 2hr at 4◦C. The pellets were
resuspended in the buﬀer (200mM Tris [pH 8] and 100mM
EDTA)anddigestedwith1mg/mlofproteinaseK(Sigma)in
the presenceof 0.5% SDS at60◦Cfor overnight. The digested
samples were extracted twice with phenol:chloroform (1:1)
and the DNA was precipitated with ammonium acetate and
ethanol.
For isolating circular viral DNA, the Hirt extraction
method was used [22]. Brieﬂy, BHK-21 cells were infected
at MOI of 100PFU/cell and cells were harvested at 3hr
after infection in PBS. The cell pellet was resuspended in
the buﬀer containing 10mM Tris (pH 8), 10mM EDTA,
0.5% SDS, and 1M NaCl. The sample was then incubated
at 4◦Cf o ro v e r n i g h ta n ds p u nd o w na t1 4 , 0 0 0r p mf o r
20min at 4◦C. The supernatant was digested with proteinase
K(60μg/ml)and RNaseA(30μg/ml)at37◦C for30min. The
DNAwasextractedtwicewithphenol:chloroform(1:1)and
precipitated with ammonium acetate and ethanol. The pellet
was resuspended in TE and 1μL was used to electroporate
E.coli DH10B.
All the BAC plasmids were isolated by the Midi-Prep
kit (Qiagen) according the modiﬁcations suggested by the
manufacture.
2.5. DNA Transfection and Electroporation. For transfec-
tion of BHK-21 cells, Lipofectamine Plus (Invitrogen) was
used according to the manufacture’s recommendations. To
remove the BAC sequence, a Cre recombinase expression
plasmid was co-transfected with the viral BAC plasmid. For
electroporation of DH10B (Invitrogen), a Gene Pulser II
system (Bio-rad) with 0.1-cm cuvettes (Fisher) was used.
For reporter assays, 10ng of a ﬁreﬂy luciferase construct
driven by the ISRE (interferon-stimulated response element)
promoter and 1ng of a Renilla luciferase construct driven by
the housekeeping PGK (phosphoglycerate kinase) promoter
were transfected into 293T cells seeded in 48-well plates
togetherwith100ngofaproteinexpressionplasmidofaviral
gene. One day later, the transfected cells were treated with
interferon α (IFN-α) and 24 hours (24hrs) later, the total cell
lysates were harvested for Dual Luciferase Assay (Promega).
The normalized value was obtained by dividing the ﬁreﬂy
luciferase reading with the Renilla luciferase activity of each
sample.
2.6. Analysis of Viral DNA. To analyze virion DNA and BAC
plasmids, digestion of restriction enzymes was performed
and the products were separated on 0.7% agarose gel. The
gel was then transferred onto a Hybond N+ membrane
(Amersham). The membrane was then hybridized with
isotope-labeled probes and the signals were developed as
previously described [21]. To quantify the copy number of
viral DNA, quantitative real-time PCR was performed using
primers and probes derived from the M9 gene as previously
described [23].
2.7. Mice, Lung Titers, and Reactivation Assays. Female
Balb/cmice(CharlesRiverlaboratories,Wilmington,Mass.),
5-6 weeks-old, were ﬁrst anesthetized by intraperitoneal
injection of a mixture of Ketamine and Xylazine (100mg/Kg
and 2mg/Kg) and then inoculated intranasally with 20PFU
of each virus in 20μl of DMEM. At the times indicated,
lungs and spleens were harvested and weighed. To determine
the viral titers in the lungs, serial dilutions of the tissue
homogenates were incubated with BHK-21 cells for plaque
assays. Single-cell suspensions were obtained from the
spleens and subjected to reactivation assays. Serial numbers
of splenocytes were laid onto BHK-21 cells and after 6
days BHK-21 cells were ﬁxed to determine the numbers of
plaques. The plaques are referred to as infectious centers
a n de a c hi n f e c t i o u sc e n t e ra r i s e sa sar e s u l to fav i r u s
reactivating from latency. Preformed viruses in splenocytes
were examined by freeze-thawing cells once prior to incu-
bating with BHK-21 cells and no plaques were detected. The
viral copy numbers present in splenocytes were determined
by quantitative real-time PCR described in the previous
section.4 Journal of Biomedicine and Biotechnology
2.8. Allelic Exchange. The pORF11S(BAC) plasmid was
generated by RecA-mediated allelic exchange in E. coli., as
described by [15]. Brieﬂy, the donor strain is GS111 carrying
the shuttle plasmid, pORF11S(GS284), and the recipient
strain is GS500(recA+) harboring pMHV-68(BAC). The
shuttle plasmid contains an ampicillin-resistant marker and
the negative selection marker SacB, which causes the toxicity
to bacteria in the presence of sucrose. A chloramphenicol-
resistance marker is located within the BAC sequence.
Conjugation was done by cross-streaking the donor and the
recipient strains. Cointegrates were selected by growing in
the presence of chloramphenicol (34μg/ml) and ampicillin
(100μg/ml) and resolved by 8-hr growth in the presence
of chloramphenicol only. After resolution, negative selection
againstthebacteriaretainingtheshuttleplasmidwasdoneby
growing in the presence of 5% sucrose and chloramphenicol
on LB plates lacking NaCl. The resulting colonies were
streaked on LB plates containing either chloramphenicol or
ampicillin. The recombinants that lost the integrated shuttle
plasmid were chloramphenicol resistant and ampicillin sen-
sitive. The incorporation of the stop codons was determined
by PCR and restriction enzyme digestion to look for the
insertion of new sites engineered next to the stop codons.
3. Results andDiscussion
3.1. Construction of a Full-Length MHV-68 BAC. To facilitate
genetic manipulation of MHV-68, the viral genome was
cloned as a BAC plasmid and mutagenized in E. coli, based
on a strategy used for mutagenesis of MCMV [15]. First,
a recombinant MHV-68 bearing the BAC sequence was
constructed. The locus chosen for the insertion of the BAC
sequence is nt 1891 [1]. The site has been used for insertion
in our laboratory to construct several recombinant viruses
which replicated comparably to wild-type MHV-68 in vitro
and in vivo. The plasmid pBeloBAC11 was modiﬁed to
contain two tandem loxP sites for the excision of the BAC
sequence mediated by the Cre recombinase. To promote
the selection of the BAC-inserted recombinant virus, an
expression cassette of the puromycin resistance gene was also
inserted into pBeloBAC11. The resultant modiﬁed plasmid
designatedaspBAC(loxP+puro),waslinearizedbetweentwo
loxP sites and inserted into a StuI site of a 4.2kb MHV-68
sequence such that the BAC sequence was ﬂanked by regions
of 1.8kb (nt 106–1891) and 2.4kb (nt 1892–4340). This ﬁnal
construct was co-transfected into BHK-21 cells with puriﬁed
virion DNA from MHV-68(EGFP), containing an EGFP
insertion at nt 1891. The recombinant virus was screened
for the loss of green ﬂuorescence. After several rounds of
puriﬁcation by limiting dilutions, the recombinant virus,
MHV-68(BAC), was obtained and its genomic structure was
analyzed by restriction enzyme digestion (Figure 1(b), lane
2). The virion DNA of MHV-68(BAC) exhibited an expected
pattern of restriction enzyme digestions. As a result of the
insertion of the BAC sequence at nt 1891, the wild-type
12.7-kb EcoRI fragment (labeled with an asterisk in lane
1) were replaced by the 3.2-kb and 20kb fragments in the
digested MHV-68(BAC) DNA (labeled with a and b in lane
2). Similarly, the wild-type 6.1-kb HindIII fragment (labeled
with an asterisk in lane 1) was replaced by the 2.9- and 11.5-
kb fragments (labeled with d and e in lane 2) in the digested
MHV-68(BAC) DNA.
Next, the circular viral genomes of MHV-68(BAC) were
harvested from infected BHK-21 cells by the Hirt extraction
method and then electroporated into E. coli DH10B. The
plasmids from several colonies were prepared and digested
with HindIII to identify the clone that contains the full-
length MHV-68 genome. One clone, pMHV-68(BAC), was
analyzed by EcoRIa n dHindIII digestions (Figure 1(b), lane
3). Compared to MHV-68(BAC) virion DNA (Figure 1(b),
lane 2), the only diﬀerence is the appearance of a larger
fragment (labeled with F in lane 3) derived from the fused
terminal fragment due to the circular nature of the BAC
plasmid.
3.2. Characterization of the BAC-Derived Viruses. Transfec-
tion of the pMHV-68(BAC) into BHK-21 initiated viral lytic
replication and led to the formation of plaques. A similar
amount of wild-type MHV-68 virion DNA was transfected
as a control and the appearance of plaques was about at
the same time, 3 days after transfection. The supernatant
containing the reconstituted virus, pMHV-68(BAC)v, was
harvested to infect fresh BHK-21 cells to produce more
viruses and obtain virion DNA for the analysis of restriction
enzyme digestions. As expected, the restriction pattern of
virion DNA of pMHV-68(BAC)v (Figure 1(b), lane 4) is
identical to MHV-68(BAC) (Figure 1(b), lane 2). In order
to remove the rather large insert of the BAC sequence
(10kb), pMHV-68(BAC)v was co-transfected with a protein
expression plasmid of Cre recombinase. The resultant pool
of viruses was subjected to limiting dilution and screened by
PCR for the absence of the BAC sequence. The virus, MHV-
68(loxP), lacking the BAC sequence but retaining one copy
of the loxP site, was then ampliﬁed in BHK-21 cells to obtain
virion DNA for analyses. After Cre-mediated recombination,
there is ∼200-nt BAC sequence left on the genome of MHV-
68(loxP), which causes a shift in the 6.1-kb HindIII wild-
type fragment (labeled with an asterisk in lane 1) to a larger
fragment (labeled with f in lane 5).
Next, the growth kinetics of pMHV-68(BAC)v and
MHV-68(loxP) were examined by determining their
multiple-growth curves on BHK-21 cells. These two
viruses replicated indistinguishably from each other and
comparably to wild-type MHV-68 (Figure 2). Thus, the
10-kb insertion of the BAC sequence did not signiﬁcantly
aﬀect the replication of MHV-68 in cultured cells.
One major advantage of studying MHV-68 is the avail-
ability of an in vivo infection mouse model. Thus, we
neededtodeterminewhetherthereconstitutedvirusbehaved
similarly to the wild-type virus in mice. Balb/c mice were
intranasally inoculated with 20 PFU of wild-type MHV-
68, pMHV-68(BAC)v, or MHV-68(loxP). At the peak of
acute lytic infection in the lungs, mice infected with MHV-
68(loxP) generated comparable viral titers to those infected
with wild-type MHV-68 (Figure 3). The viral titers in mice
infected with pMHV-68(BAC)v were slightly lower (2.6-
fold) than those infected with wild-type MHV-68 but the
diﬀerence did not reach the statistical signiﬁcance (p>0.1).Journal of Biomedicine and Biotechnology 5
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Figure 1: The genomic structures of the MHV-68 recombinant viruses and the MHV-68 BAC plasmid. (a) Schematic diagram of the
construction of the MHV-68 BAC virus. Shown is the left end of the viral genome encompassing terminal repeats and ORFs M1–M3.
The BAC vector sequence and a puromycin expression cassette was recombined into the locus where the EGFP expression cassette was
inserted in MHV-68(EGFP). MHV-68(BAC) was selected for the loss of the EGFP expression. The pMHV-68(BAC) plasmid was obtained
by electroporating the circular genome of MHV-68(BAC) into DH10B cells. Following transfection of pMHV-68(BAC) into BHK-21 cells,
the reconstituted virus, pMHV-68(BAC)v, was generated. The structures of pMHV-68(BAC) and pMHV-68(BAC)v are identical to MHV-
68(BAC), except that pMHV-68(BAC) is circular with termini fused. To remove the BAC insert ﬂanking by loxP sites, pMHV-68(BAC)v was
co-transfected with a Cre recombinase expression plasmid and MHV-68(loxP) was isolated. The sites of HindIII are indicated with H and
the ones of EcoRI were indicated with E. (b) Restriction enzyme analysis of the genome of MHV-68 recombinant viruses and the MHV-68
BAC plasmid. Each DNA sample was digested with either EcoRIo rHindIII. Lane 1 is virion DNA of wild-type MHV-68; lane 2 is virion
DNA of MHV-68(BAC); lane 3 is the plasmid DNA of pMHV-68(BAC); lane 4 is virion DNA of pMHV-68(BAC)v; lane 5 is virion DNA
of MHV-68(loxP) and lane 6 is virion DNA of MHV-68(EGFP). The wild-type fragments which were eliminated due to the insertion of
the BAC sequence were marked with asterisks. The fragments marked with a, b, d, and e, were generated because of the BAC insert. The
fragments marked with c and f, resulted from the removal of BAC, 200bp larger than the fragments indicated with asterisks. The fragments
marked with F were from the fused termini of the circular pMHV-68(BAC). On the bottom of each agarose gel picture is the corresponding
Southern blot using the probe spanning nt 51–6298. The laddering patterns in EcoRI-digested samples were due to various number of
repeats on the linear virion DNA but not present in pMHV-68(BAC) (lane 3).6 Journal of Biomedicine and Biotechnology
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Figure 2: pMHV-68(BAC)v and MHV-68(loxP) displayed similar
growth curves to wild-type MHV-68 in vitro. BHK-21 cells were
infected with each virus at an MOI of 0.05. The viral titers in cells
and the supernatants harvested at various times after infection were
determined by plaque assays.
Atday11afterinfection,noinfectiousviruseswererecovered
from any group of mice. The results indicate that the virus
derived from our BAC clone infects and replicates in the
l u n g sa sw e l la sw i l d - t y p eM H V - 6 8a n dt h ep r e s e n c eo f
the BAC insert does not signiﬁcantly interfere with viral
productive infection in the lungs.
Following acute infection in the lungs, MHV-68 estab-
lishes latency in the spleen accompanied with splenomegaly.
The spleens of mice infected either with wild-type MHV-
68 or MHV-68(loxP) enlarged to similar extents com-
pared to uninfected mice (Figure 4(a)). The levels of
latently-infected cells determined by infectious center assays
were also comparable between mice infected with wild-
type virus and those with MHV-68(loxP) (Figure 4(b)).
Similar results were obtained from measuring the viral
DNA copy numbers present in the spleen (Figure 4(c)).
In contrast, the virus retaining the BAC insert failed
to establish the wild-type level of latency in the spleen.
There were 100-fold fewer infectious centers and 10-
fold lower viral DNA copies in the spleen compared to
those from mice infected with wild-type MHV-68. Taken
together, the BAC insertion in the viral genome severely
attenuated viral splenic latency and its removal restored
the ability of MHV-68 to establish the wild-type level of
latency.
The present study indicates that our MHV-68 BAC clone
is suitable for genetic mutagenesis to investigate the function
of individual viral genes. In fact, random mutagenesis
by transposon insertions was already conducted on this
MHV-68 BAC plasmid, and the resultant mutant viruses
were used to identify genetic requirements for productive
replication in vitro and in vivo [19]. Moreover, we also
constructed a ﬁreﬂy luciferase-expressing virus using the
MHV-68 BAC genetic engineering system described here
and examined viral infection via the whole body biolu-
minescence imaging [24]. It was shown that the virus
derived from our MHV-68 BAC clone mainly replicates
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Figure 3: Infection of pMHV-68(BAC)v and MHV-68(loxP)
produced similar viral titers to wild-type MHV-68 in lungs of mice.
Balb/c mice were infected with 20 PFU of each virus via intranasal
inoculation. At day 9 after infection, the lungs were harvested and
homogenized for determining viral titers using plaque assays. Each
symbol represents the lung titer of individual mice.
in the lung following intranasal inoculation and produces
infectious virus that can be recovered from it, which is
similar to what has been observed for wild-type MHV-68
[5].
Although a diﬀerent MHV-68 BAC plasmid was con-
structed and published previously by Adler et al. [25], we
independently carried out the cloning process and inserted
the BAC sequence at a diﬀerent location. Our BAC sequence
insertion is at 1.8kb from the terminal repeats of the genome
while Adler et al. inserted the BAC sequence adjacent to the
repeats [25]. We showed that the presence of the 10-kb BAC
sequence did not signiﬁcantly reduce the replication ability
of the virus in cultured cells or in the lungs of mice, unlike
the previous MHV-68 BAC clone constructed in the other
laboratory [10].
Despite that the BAC insertion does not interfere with
viral lytic replication, it severely attenuates viral abil-
ity to establish latency in the spleen. We observed less
splenomegaly, 10-fold lower viral DNA copy numbers and
100-fold reduction in viral reactivation from splenocytes.
This result is similar to the MHV-68 BAC clone made by
Adleret al.[10],butnot surprising, since severalstudies have
shown that the left end of the MHV-68 genome is important
for viral latency [26–29]. In addition, several microRNA
genes were identiﬁed on the left end of the genome [30]. It
is possible that the insertion of a large BAC sequence alters
the expression of the neighboring genes. Thus, it is necessary
to remove the BAC sequence using Cre recombinase prior to
the study of viral latency.Journal of Biomedicine and Biotechnology 7
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Figure 4: The removal of the BAC insert restored the ability of MHV-68 to establish viral latency in the spleens of mice. Balb/c mice were
infected with 20PFU of each virus via intranasal inoculation. At day 14-15 after infection, the spleens were weighed and harvested for
reactivation assays and quantiﬁcation of viral DNA copy numbers. Each symbol represents the weight of the spleen (a), the number of
infectious centers (b), and the viral DNA copies (c) of individual mice.
3.3. Site-Speciﬁc Mutagenesis of ORF11. ORF11 is one of
MHV-68 genes whose functions remain unknown. Previ-
ously, ORF11 was shown to be a virion component but
dispensable for viral replication in vitro [31]. A recent study
ontheEBVORF11homologue(alsoknownasLF2)indicates
that this viral protein play a role in counteracting type I
interferon (IFN) responses [32]. Here, we used transient
transfection assays to examine whether MHV-68 ORF11
(M-ORF11) aﬀected the IFN-mediated induction of an
ISRE (interferon-stimulated response element) reporter. We
also included transfection of a KSHV ORF11 (K-ORF11)
expression plasmid as a comparison. The induction by IFN-
α was 10∼12-fold in the cells transfected with an empty
vector but reduced to 2-fold in the cells receiving the M-
ORF11 plasmid (Figure 5(a)). Interestingly, K-ORF11 did
not have the same inhibitory eﬀect as M-ORF11. Neither
did expression of other MHV-68 genes, such as ORF48 and
ORF46,inhibitedtheinductionofISREreporteractivity.The
reporter assays indicate that M-ORF11 can reduce the IFN
responses but not K-ORF11.8 Journal of Biomedicine and Biotechnology
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Figure 5: ORF11 is not required for MHV-68 to resist IFN-α. (a) ORF11 inhibits the IFN-mediated induction of the ISRE reporter activity.
293T cells were transfected with the ISRE-driven ﬁreﬂy luciferase reporter and the protein expression plasmid of a viral ORF indicated at
the bottom of the graph. For normalization, a Renilla luciferase construct driven by the housekeeping PGK promoter was included in each
transfection. One day after transfection, the cells were either mock treated or treated with 3 × 104 units/ml of IFN-α and 24 hrs later, the
total lysates were harvested for Dual Luciferase assays. For another experiment, the cells were treated with 105 units/ml of IFN-α. The fold
of induction was derived by dividing the normalized valuses of treated samples with those of mock treated samples. (b) Restriction enzyme
analysis of the genomes of pORF11S(BAC)v and ORF11S(loxP). Each virion DNA sample was digested with either combination of SacI
and PacI, EcoRIo rHindIII. Lane 1 is virion DNA of wild-type MHV-68; lane 2 is virion DNA of pMHV68(BAC)v; lane 3 is virion DNA of
MHV68(loxP); lane 4 is virion DNA of pORF11S(BAC) and lane 5 is virion DNA of ORF11S(loxP). The wild-type fragments marked with
solid squares were eliminated in lanes 4 and 5 due to the insertion of stop codons. The a and b fragments were generated as a result of the
insertion of the stop codons. The c fragments were resulted from the removal of the BAC sequence. (c) Lack of ORF11 does not increase the
sensitivity of MHV-68 to IFN-α. NIH3T3 cells were pretreated with 100 units/ml of IFN-α for 16hrs and then infected with MHV-68(LoxP)
or ORF11S(LoxP) at an MOI of 0.01. The whole cultures were harvested at various times post-infections for plaque assays to determine the
viral titers.
In order to determine the biological signiﬁcance of
the anti-IFN activity of M-ORF11 in the context of viral
replication,weconstructedanORF11-deﬁcientmutantvirus
using the pMHV-68 BAC plasmid. The recA-mediated allelic
exchange method was used to introduce translational stop
codons after N-terminal 41 amino acids of the predicted 388
amino-acid ORF11 gene product. The corresponding shuttle
plasmid to transfer the stop codons into the pMHV-68 BAC
plasmid was constructed and veriﬁed by sequencing. After
allelic exchange in RecA+E. coli as described in Section 2,
the recombinant BAC plasmid, pORF11S(BAC), was isolated
and examined by SacIa n dPacI digestion. To reconstitute
the virus, the pORF11S(BAC) plasmid was transfected into
BHK-21 cells together with a Crerecombinase expression
plasmid. The pool of viruses containing both ORF11S(BAC)
and ORF11S(loxP) was subjected to limiting dilution and
screened for the absence of the BAC sequence. One isolate,
ORF11S(loxP), was selected and its genomic structure was
examined by restriction analysis. As expected, the virion
DNA of ORF11S(BAC) and ORF11S(loxP) have the similarJournal of Biomedicine and Biotechnology 9
restriction patterns of SacIa n dPacI altered in the fragment
containing the ORF11 coding sequence (Figure 5(b),l a n e s
4 and 5) compared to wild-type pMHV68(BAC)v and
MHV68(loxP). The 7.0-kb SacI wild-type fragment (labeled
with squares in lanes 1–3 of Figure 5(b)) containing the
ORF11 coding sequence is replaced by the 4.7- and 2.2-
kb fragments (labeled with a and b in lanes 4–5) as a
result of the new PacI site introduced along with the stop
codons into the ORF11. The removal of the BAC sequence
led to the appearance of the 2.7-kb SacI in ORF11S(loxP)
(labeled with c in lane 5 of Figure 5(b)), which is also
detected in MHV68(loxP) (Figure 5(b), lane 3). This 2.7-kb
fragment is 200bp larger than the 2.5-kb wild-type fragment
(Figure 5(b), lane 1) as a result of the remaining loxP
and BAC vector sequence. Restriction digestions by HindIII
and EcoRI displayed similar patterns compared to the
wild-type pMHV68(BAC) plasmid, indicating no detectable
illegitimate DNA rearrangements during recombination in
E. coli.
To determine whether ORF11 contributes to the resis-
tance of MHV-68 to type I interferons, we studied
the multiple-step growth curves of MHV68(loxP) and
ORF11S(loxP) with or without the treatment of IFN-α.
For this experiment, we used NIH3T3 cells and mouse
IFN-α. The ORF11S(loxP) virus replicated comparably to
MHV68(loxP) in the absence of interferons, indicating
that ORF11 is not required for viral replication in vitro
(Figure 5(c)), consistent with the previous results [19, 31].
Furthermore, the lack of ORF11 did not increase the
sensitivity of MHV-68 to the treatment of IFN-α. There were
about3∼4-foldreductionsbyIFN-αinthepeakviraltitersof
both MHV68(loxP) and ORF11S(loxP) (Figure 5(c)). There
are two major interpretations for this result. One is that
the anti-IFN activity of ORF11 observed in the transient
transfection reporter assay is a nonspeciﬁc eﬀect due to
overexpression of the protein. This is unlikely since overex-
pression of other viral proteins, especially K-ORF11, does
not have the same inhibitory eﬀect. The other interpretation
is that there are additional viral proteins with similar anti-
IFN functions to complement the loss of ORF11. It is not
unusual for large DNA viruses, such as herpesviruses, to
utilize multiple viral proteins to counteract type I interferon
responses. As reviewed elsewhere [33–35], several KSHV
proteins can inhibit the functions of IRF3 and IRF7, the
two important transcriptional factors that regulate type I
interferon responses. Therefore, it is likely that interferons
play an important role in the control of gamma-herpesvirus
infection and the viruses utilize multiple mechanisms to
counteract the host responses for their survival.
To examine the role of ORF11 in MHV-68 infection in
vivo, Balb/c mice were intranasally inoculated with 20 PFU
ofwild-typeMHV-68,MHV68(loxP),orORF11S(loxP).The
peak viral titers in the lungs were similar among groups
of mice at day 9 after infection (Figure 6(a)). At day 11,
no infectious viruses were detected in any mice (data not
shown). The viral latency at day 15 after infection in the
spleens of mice infected with ORF11S(loxP) was comparable
to that in the mice infected with wild-type MHV-68
(Figure 6(b)). Although MHV68(loxP) seemed to establish
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Figure 6: ORF11 is not required for viral infection in Balb/c
mice. (a) The acute lung viral titers. Balb/c mice were intranasally
inoculated with 20PFU of each virus. The lungs were harvested at
day9afterinfectionandthetitersweredeterminedbyplaqueassays.
Shown are the means of viral titers from 3 mice per virus infection
and the standard errors of the means. (b) The viral latency in
spleens. 20PFU of each virus was inoculated into Balb/c mice. The
spleens were harvested at day 15 after infection and the amounts
of latent virus were determined by infective center assays. (c) The
copy numbers of viral genomes in the spleens harvested at day 15
after infection. 50ng of splenic DNA was used for real-time PCR to
determine the viral DNA copy numbers. Shown are the means from
3 mice per virus infection and the standard errors of the means.
lower levels of latency than the other two groups of infected
mice, this diﬀerence did not reach statistical signiﬁcance.
Similar results were obtained from the analysis of DNA
copy numbers measured by real-time PCR. In conclusion,
ORF11 is not required for MHV-68 to establish lytic and
latent infections in mice, consistent with the previous studies
[19, 31].
One notable piece of information about ORF11 is that
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be derived from the viral dUTPase gene, ORF54, based
on sequence similarities and structural predictions [36].
However, ORF10 and ORF11 do not retain the critical
residues at the catalytic site of dUTPase and thus they are
not expectedto have anyenzymatic activity. Since these three
proteins, ORF54, ORF10, and ORF11, have some degrees
of homology, it may be that they have the same unknown
functions, such as anti-IFN activity, and can complement
each other; thus, elimination of ORF11 alone is not suﬃcient
to generate a phenotype. Nevertheless, it is also possible that
ORF11 is only required under speciﬁc circumstances. For
example, the virus deﬁcient in the M3 gene only exhibited
ad i ﬀerent phenotype from the wild type when infecting
CNS [37]. We have not tested other aspects of virus infection
besides replication in the lungs and latency in the spleens.
4. Conclusions
The MHV-68 BAC plasmid generated in our laboratory has
been extensively used to construct various mutant viruses.
In this report, we provide the details for the cloning and
characterization of our MHV-68 BAC. In comparison to
the wild-type MHV-68, the virus reconstituted from the
BAC plasmid replicated comparably in cultured cells and
producedsimilartitersinthelungofinfectedmice.However,
removal of the BAC insertion is necessary for the studies of
viral splenic latency. In summary, our MHV-68 BAC plasmid
is a valid and useful resource for genetic mutagenesis.
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